WHO ICTRP trial
Erythropoietin for neuroprotection in preterm infants: A longitudinal randomized…
CTRI/2024/06/068517 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/06/068517 |
|---|---|
| Public title | Erythropoietin for neuroprotection in preterm infants: A longitudinal randomized trial |
| Scientific title | Longitudinal effects of erythropoietin as a neuroprotective therapy among preterm neonates born less than 32 weeks of gestation: A randomized control trial - NIL |
| Primary sponsor | Mahatma gandhi medical college |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: P073- Preterm [premature] newborn [other] |
| Interventions | Intervention1: Injection Erythropoietin: Eligible Infants will be divided into two groups (Intervention and control group) by block Randomisation with each block containing 4 infants. Intervention group will be receiving Erythropoietin with… |
| Registration date | Jun 6, 2024 |
| Target size | 54 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: